|« Previous month||Next month »|
29-Nov-2012 - The industry group that prompted the USP to delay new elemental impurities standards says even when completed, ICH Q3D will take time to implement.
29-Nov-2012 - Belgian biopharmaceutical company UCB has agreed to sell its manufacturing plant in Vapi, India to API maker Exemed Pharmaceuticals.
29-Nov-2012 - The group behind the excipient certification scheme Excipact will train SGS and blue inspection body GmbH auditors under agreements signed this week.
28-Nov-2012 - The US Federal Trade Commission (FTC) says making insignificant reformulations to drugs to block generic competition violates antitrust laws.
28-Nov-2012 - Hovione and Solvias have become the latest suppliers to team on drug solubility and bioavailability services in a new deal announced today.
28-Nov-2012 - in-PharmaTechnologist.com presents its latest round-up of movers and shakers in the world of pharmaceuticals, including news from Cipla, Dr. Reddy’s and Immunogen.
27-Nov-2012 - Pfizer is re-jigging its failed virtual trial model and could re-launch the programme as soon as 2013.
27-Nov-2012 - The bioavailability market lacks a leader that can offer comprehensive solutions according to Merck Millipore, which has set its sights on filling the gap through investments and a new lab....
27-Nov-2012 - "Church brand Chihpen Tianyun capsule”,“wind pain Kang membrane ball” and “brain Xuesaitong pill” are just three of the ‘drug’ products named and shamed by China’s SFDA in a clampdown on...
27-Nov-2012 - The USP has delayed new elemental impurities standards but is still confident they can be harmonized with ICH Q3D even if May 2014 implementation target is kept.
27-Nov-2012 - Rhenovia Pharma says the multi-drug delivery capabilities of its transdermal-patch could have wider application.
26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
26-Nov-2012 - APIs made in Switzerland won’t need ‘written confirmation’ of quality after the EC deemed the country's manufacturing standards meet its requirements.
26-Nov-2012 - Indian Plans to hand quality oversight of APIs shipped to Europe to ‘competent authority’ are still being discussed according to Pharmexcil.
26-Nov-2012 - Euticals Limited has halted API production at its Welsh site after local authorities found it was housing “substantial” quantities of a potentially explosive chemical.
22-Nov-2012 - The US FDA wants IRBs to remember it is their responsibility to check investigator qualifications, make sure sites are up to code and say if an IND is necessary for...
22-Nov-2012 - in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics and Bend Research.
22-Nov-2012 - The European Commission (EC) has asked the industry how long it will take to change labels of drugs marked for additional post-market monitoring.
22-Nov-2012 - Johnson Matthey saw an uptick in its API business thanks to demand for “higher margin” products.
22-Nov-2012 - Brazilian drug regulator Anvisa wants to engage with the pharmaceutical industry on the disposal of unused drugs.
21-Nov-2012 - BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.
21-Nov-2012 - US insurers will cover more medicines under Obamacare according to a document published by the Department of Health and Human Services (DHSS) in the Federal Register earlier this week.
21-Nov-2012 - Fujifilm has developed a new “pain-free” alternative to hypodermic needles which delivers drugs through a sheet of material covered in tiny dissolvable needles.
21-Nov-2012 - Improper antibiotic use is driving the ‘Superbug’ epidemic but irresponsible promotional may be exacerbating the problem according to the WHO.
20-Nov-2012 - The US FDA has finally adopted the revised ICH Q11 guidelines on drug substance manufacturing nearly six months after European regulators embraced the guidelines.
20-Nov-2012 - CRO Spinnovation Biologics says its cell culture optimization technique complies with analytical methods detailed in ICH Q2A and Q2B guidelines.
20-Nov-2012 - Brazil wants to buy pharmaceutical manufacturing technology from the Ukraine as part of a $4.5bn investment plan.
20-Nov-2012 - The Indian Government plans to offer financial assistance to small and medium pharma enterprises (SMEs) in a bid to drive the industry.
20-Nov-2012 - Marinomed Biotechnologies is set to take on the ‘common cold’ in China with a new patent for an anti-viral polymer technology that prevents rhinovirus infection.
19-Nov-2012 - Researchers believe a new nanoparticle could provide the first MS therapy that does not suppress the immune system.
19-Nov-2012 - Micromacinazione has bought the micronization arm of Switzerland’s Neo-Micro AG, citing growth in the API sector as the key driver for the move.
19-Nov-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest appointments in the pharmaceutical industry, including news from Dendreon, Shire and Targacept.
16-Nov-2012 - Rousselot has said it plans to increase gelatine prices 7% up to low double digit levels for 2013 as continued growth in demand has not been met by raw material supply.
15-Nov-2012 - Domestic regulatory efforts to improve ingredient quality will increase costs but Indian industry will remain competitive, according to the Secretary of Commerce.
15-Nov-2012 - Brazilian drug regulator Anvisa has called for increased pharmacovigilance and more effective reporting of adverse reactions by authorities worldwide.
15-Nov-2012 - New Communist Party General Secretary Xi Jinping wants to improve medical care and says China needs to “learn more about the world.”
14-Nov-2012 - An industry consortium has asked the USP to delay new elemental impurities chapters on concerns that lack of harmonization with ICH Q3D will create compliance difficulties, shortages and additional costs....
14-Nov-2012 - Regulators should force pharmaceutical firms to source from BSE-safe countries according to Rocky Mountain Biologicals' CEO.
14-Nov-2012 - SAFC has added 25 new raw materials to its portfolio of PharmaGrade products, expanding its early phase material offering.
14-Nov-2012 - A new vaccine targeting technology offers both therapeutic efficacy and manufacturing advantages according to developer Vaccibody.
13-Nov-2012 - The Indian CDSCO wants drug companies to withdraw defective drugs faster and to practice for such recalls.
13-Nov-2012 - Elder Pharma hopes to increase sales to European drugmakers after receiving a certificate of suitability (CEP) for the API Diosmin.
13-Nov-2012 - The ICH says regulator uncertainty over Q7 for ingredient supply chains, contractor management and quality management systems must be resolved.
12-Nov-2012 - A European industry group says EU efforts to ensure the quality of API imports are inadequate and that mandatory inspections of overseas plants are a must.
12-Nov-2012 - Orchid Chemicals has pulled out of its joint venture with North China Pharmaceutical Corporation (NCPC) to focus efforts on India.
12-Nov-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest new appoitnments within the world of pharma and biopharma including news from J&J, Teva and Amarantus.
12-Nov-2012 - Italian regulators have lifted a temporary ban on two Novartis flu vaccines in which high levels of protein aggregates were detected.
12-Nov-2012 - Boehringer Ingelheim has withdrawn one lot of its anticoagulant Pradaxa in the US over concerns about defective packaging.
08-Nov-2012 - Drugmakers in India face the prospect of more inspections under new guidance from the country’s price setting agency, the NPPA.
08-Nov-2012 - Bayer Healthcare has partnered with Medsintez in a deal designed to allow the German firm to make and sell drugs in Russia.
08-Nov-2012 - DSM says acquisition of food formulation technology firm wont impact its pharmaceutical business.
08-Nov-2012 - MonoSol Rx says oral film vaccine collaboration could deliver product with compliance and storage benefits.
07-Nov-2012 - Barack Obama’s re-election will mean millions more US citizens have health insurance, which has significant implications for the pharmaceutical industry.
07-Nov-2012 - The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is still underserved, according to Aesica.
07-Nov-2012 - Production by Ireland’s pharmaceutical sector fell sharply in September but it is too early to say if it was part of a longer term decline, says the CSO
06-Nov-2012 - GSK has withdrawn another lot of its Infanrix Hexa vaccine over concerns about potential microbial contamination.
06-Nov-2012 - The US Pharmacopeial Convention (USP) has changed its labelling rules for heparin in a mid to reduce the number of medication errors.
06-Nov-2012 - The organisational changes BASF announced yesterday will not impact drug ingredients or excipients but intermediates will be rejigged.
05-Nov-2012 - Novartis will spend $500m on a new cell-culture based manufacturing facility in Singapore.
05-Nov-2012 - Wacker Biotech has added a low cost PEGytlation alternative to its biopharmaceutical manufacturing offering in a deal with developer XL-protein.
05-Nov-2012 - Merck Millipore and microRNA detection firm Sistemic have teamed up to develop QC kits for stem cell production.
05-Nov-2012 - Eli Lilly plans to boost its in-house insulin production capabilities will a $140m investment for its Indianapolis site.
05-Nov-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest appointments in the pharmaceutical industry, including news from Watson, OvaScience and Sirona.
|« Previous month||Next month »|